Guest guest Posted November 17, 2008 Report Share Posted November 17, 2008 Subject: The Liver UpdateTo: jeanne2113@...Date: Monday, November 17, 2008, 10:48 AM The Liver Update Donate now A Weekly Newsletter fromthe American Liver Foundation November 17, 2008 In This Issue - Fatty Liver Research - Climb to Fight Liver Disease - Liver Cancer and Diabetes - Metformin Ineffective Against Fatty Liver - A New Way to Support ALF A Look at ALF Research:Xinqing Kang, PhD Dr. Kang's study aims to describe on a molecular level how alcohol exposure leads to fat accumulation in the liver. A better understanding of the connection may point the way to new and more effective therapies for fatty liver.Read more about Dr. Kang Walk for Fun...Walk for Life! Join ALF at a Liver Life Walk and help raise awareness for liver disease.Find a Walk near you Run To Help Save 30 Million Lives Join an extraordinary group of runners and volunteers from all over the United States as we set our sights even higher for the 113th Boston Marathon on April 20, 2009.Learn more Find an ALF ChapterNear You Click here Did you know? Nonalcoholic fatty liver disease (NAFLD), an obesity-related chronic liver disease, may affect as many as one in every four adults over the age of 18. Liver LIFE Challenge Climb The Liver LIFE Challenge Climb is a pledged overnight endurance climb event on Mt. Shasta in California on June 6-7, 2009.No prior mountaineering experience is necessary, however experience with hiking and backpacking is a definite plus. You must be in good health and good physical condition before joining the climb team.Visit www.climbteam.org to learn more. Liver Cancer Patients Have High Diabetes Prevalence Reuters, November 14, 2008 - Patients with hepatocellular carcinoma (HCC) have a significantly higher prevalence of type 2 diabetes mellitus (DM) compared to the general population, according to findings from a case-control study conducted in Italy.Read more AASLD: Metformin Appears Ineffective inFatty Liver Disease MedPage Today, November 4, 2008 - Although the diabetes drug metformin caused a striking weight loss in patients with non-alcoholic fatty liver disease (NAFLD), it did not reduce steatosis, a Norwegian researcher said here.Read more Give While You Shop, Shop While You Give There is a new and easy way to support the American Liver Foundation! Simply download our GiveClicks Shopping Assistant and a portion of what you spend on-line at thousands of major retail vendors will go to the ALF. The best part is that you are making a contribution at no additional cost to you. You just simply shop on-line as you normally would and GiveClicks takes care of the rest!Download the GiveClicks Shopping Assistant today Thank you for your continued support of the American Liver Foundation. For more information on liver disease or our work as an organization, please visit our Web site or contact your local ALF chapter.Give to ALF today. Forward email This email was sent to jeanne2113@... by update@.... Update Profile/Email Address | Instant removal with SafeUnsubscribe™ | Privacy Policy. Email Marketing by American Liver Foundation | 75 Maiden Lane | Suite 603 | NEW YORK | NY | 10038 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.